Increased Risk for CVST With Thrombocytopenia in J&J COVID-19 Vaccine Recipients
This case series described the different reports of CVST with thrombocytopenia following receipt of the Johnson & Johnson COVID-19 vaccine.
General Infectious Disease
FDA Expands Pfizer-BioNTech COVID-19 Vaccine EUA to Include Adolescents
The safety of the vaccine in this patient population was based on data from 2260 adolescent participants.
WHO Increases Warning About Indian COVID-19 Variant
WHO called the B.1.617 variant of the COVID-19 virus, which has become more common in India, a “variant of concern.”
CDC Revises Website Info on How COVID-19 Spreads
The U.S. Centers for Disease Control and Prevention on Friday changed its website guidance on how COVID-19 spreads.
US Likely to Achieve July 4 COVID-19 Vaccination Target, but Challenges Remain
United States will likely achieve the President’s target of having 70% of adults vaccinated with one dose of a COVID-19 vaccine by July 4.
New Guidance: American College of Physicians Discusses Antibody Response in COVID-19 Immunity
To help clinicians and patients determine if antibodies protect against reinfection, the ACP discussed tests for diagnosing and estimating the prevalence of COVID-19.
Two Doses of BNT162b2 SARS-CoV-2 Vaccine Highly Effective
Two doses of BNT162b2 are highly effective for preventing symptomatic and asymptomatic SARS-CoV-2 infections and other outcomes.
NYC, NJ, and Connecticut to Ease COVID-19 Capacity Restrictions
Shops, restaurants, theaters, and other businesses in New York, New Jersey, and Connecticut will be allowed to operate at full capacity starting May 19.
Increased Stroke Risk in Younger Adults During the Convalescent Phase of COVID-19
As acute ischemic stroke (AIS) is a known neurologic complication in patients with COVID-19, researchers sought to evaluate AIS in the convalescent phase of infection in younger adults.
Pfizer to Seek Approval in Fall for COVID-19 Vaccine Use in Children Aged 2 to 11
EUA for the Pfizer COVID-19 vaccine to be given to children ages 2 to 11 years could be sought from the U.S. FDA by September.
- Loading...
Loading...
Next post in Pediatric Neurology
Loading... 
Loading...